TYBR Health
PrivateLast Round
Series A
Jul 21, 2026
Est. Valuation
$66M
Total Funding Raised
$39.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TYBR Health operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series A round in July 2026.
TYBR Health is a medical device and regenerative medicine company that develops bioresorbable hydrogel solutions to improve post-operative recovery by protecting healing tissues and preventing internal scarring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TYBR Health Comparables
Compare TYBR Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alafair Biosciences, Inc. | 85% | |
| ARC Medical Inc. | 84% | |
| FzioMed, Inc. | 82% |
For institutional investors. Book with your work email.
TYBR Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 21, 2026 | ||||
| Seed | Nov 26, 2025 | ||||
| Seed | Jan 31, 2025 | ||||
| Accelerator | May 29, 2024 | ||||
| Accelerator | Mar 29, 2022 | ||||
Grant | Aug 11, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TYBR Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mutual Capital Partners | Series A |
| Plug and Play Tech Center | Seed |
| MedTech Innovator | Seed, Accelerator |
| Vensana Capital | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Asymmetry Ventures | Seed, Accelerator |
| Texas Medical Center | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 47% QoQ, from 15 to 22 employees.
- Jul 21, 2026
$30M round led by Mutual Capital Partners and Vensana Capital.
For institutional investors. Book with your work email.
TYBR Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TYBR Health's valuation, stock price, and market status.
Is TYBR Health a public or private company?
TYBR Health is a private company.
What is the current stock price of TYBR Health?
TYBR Health is a private company, so its shares have no public market price. Caplight tracks TYBR Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TYBR Health worth (valuation)?
TYBR Health's valuation is estimated at $66.0M based on funding round data.
Can I buy TYBR Health stock?
TYBR Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TYBR Health's last funding round?
TYBR Health's most recent funding round was Series A on July 21, 2026.
Who are the main investors in TYBR Health?
Key investors in TYBR Health include Mutual Capital Partners, Vensana Capital.
Will TYBR Health IPO soon?
No public IPO plans have been announced for TYBR Health.
How can I track TYBR Health secondary market activity?
Caplight tracks bids, offers, and trades in TYBR Health's shares on secondary markets.